Please note that slides are for review only and not to be repurposed or published.

PART 1 — LUNG CANCER: BEYOND THE GUIDELINES

Introduction:
Dr Love

MODULE 1:
Optimal Therapeutic Approaches for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations — Dr Riely

MODULE 2:
Management of NSCLC with ALK Rearrangements or Other Targetable Abnormalities — Dr Camidge

MODULE 3:
Current and Emerging Paradigms in the Treatment of Small Cell Lung Cancer (SCLC) — Dr Liu

MODULE 4:
Integration of Immune Checkpoint Inhibition into the Management of Locally Advanced NSCLC — Dr Spigel

MODULE 5:
Available Data with and Current Clinical Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other Systemic Therapies for Patients with Metastatic NSCLC — Prof Peters

Live Poll Results:
Download

PART 2 — BLADDER CANCER: BREAKFAST WITH THE INVESTIGATORS

Slide Presentation:
Download

Live Poll Results:
Download

PART 3 — GASTROINTESTINAL CANCERS: CURRENT QUESTIONS AND CONTROVERSIES

MODULE 1:
Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry and Dr Finn

MODULE 2:
Pancreatic Adenocarcinoma (PAD) — Dr Bekaii-Saab and Dr O’Reilly

MODULE 3:
Gastroesophageal Cancers — Dr Chao and Dr Janjigian

MODULE 4:
Colorectal Cancer (CRC) — Prof Arnold and Dr Kopetz

Live Poll Results:
Download

PART 4 — OVARIAN CANCER: BREAKFAST WITH THE INVESTIGATORS

Slide Presentation:
Download

Live Poll Results:
Download

PART 5 — LYMPHOMA, CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA: MEET THE PROFESSORS

MODULE 1:
Multiple Myeloma (MM) — Dr Raje and Dr Richardson

MODULE 2:
Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL) — Dr Cheson and Dr LaCasce

MODULE 3:
Hodgkin Lymphoma (HL), Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL) and T-Cell Lymphoma (TCL) — Dr Abramson and Dr Smith

Live Poll Results:
Download

PART 6 — MELANOMA: BREAKFAST WITH THE INVESTIGATORS

Slide Presentation:
Download

Live Poll Results:
Download

PART 7 — BREAST CANCER: INTERACTIVE TUMOR PANEL

Introduction:
Dr Love

MODULE 1:
Available and Emerging Data Sets Shaping the Management of Localized HER2-Positive Breast Cancer (BC) — Dr Rugo

MODULE 2:
Use of Genomic Classifiers in Clinical Decision-Making for Patients with ER-Positive Early BC — Dr Kaklamani

MODULE 3:
Selection and Sequence of Therapy for ER-Positive, HER2-Negative Metastatic BC (mBC); Novel Agents and Strategies Under Evaluation in ER-Positive Disease — Prof André

MODULE 4:
Immunotherapy as a Rational Therapeutic Strategy in BC — Dr Tolaney

MODULE 5:
Protocol and Off-Protocol Decision-Making for Patients with HER2-Positive mBC — Dr Pegram

MODULE 6:
Role of PARP Inhibitors, Novel Agents in mBC; Male Breast Cancer — Dr Traina

Live Poll Results:
Download